Alexander E. Perl

15.7k citations
200 papers · 6.3k · 3 hit papers · h-index 37

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 148
    • Chronic Myeloid Leukemia Treatments 95
    • Multiple Myeloma Research and Treatments 22
    • Hematopoietic Stem Cell Transplantation 16
    • Chronic Lymphocytic Leukemia Research 64
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 22

Alexander E. Perl

192 papers receiving 6.2k citations

Hit Papers

Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia 2022 · 123 citations
1230+5+10Years since publication4008001.2k

Peers

Alexander E. Perl
Comparison fields: 5 of 110
  • Hematology 3.9k
  • Genetics 1.6k
  • Cancer Research 1.1k
  • Molecular Biology 3.2k
  • Oncology 942
Replace Daniel A. Pollyea with:
Daniel A. Pollyea United States
B. Douglas Smith United States
Jeffrey E. Lancet United States
Shaoguang Li United States
Ilene Galinsky United States
Jonathan L. Kaufman United States
Junia V. Melo United Kingdom
Raoul Tibes United States
François‐Xavier Mahon France
Margaret Dugan United States
Alexander E. Perl relative to Daniel A. Pollyea United States Daniel A. Pollyea's profile →
Citations per field
00.5×1.7×
Daniel A. Pollyea · 1×
Citations per year

Countries citing papers authored by Alexander E. Perl

Since Specialization
Citations

This map shows the geographic impact of Alexander E. Perl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander E. Perl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander E. Perl more than expected).

Fields of papers citing papers by Alexander E. Perl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander E. Perl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander E. Perl. The network helps show where Alexander E. Perl may publish in the future.

Co-authors

The 25 scholars most cited alongside Alexander E. Perl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexander E. Perl Line = papers co-authored together Alexander E. Perl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Hit paper breakdown →
20101483
2
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Hit paper breakdown →
2012542
3 2005176
4 2019173
5 2014172
6 2010150
7 2013146
8 2012128
9 2012124
10
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Hit paper breakdown →
2022123
11 2017120
12 2018119
13 2016110
14 2012104
15 2020101
16 201893
17 200986
18 200982
19 201680
20 201768

About Alexander E. Perl

Alexander E. Perl is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 200 papers that have together received 6.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (148 papers), Chronic Myeloid Leukemia Treatments (95 papers), Chronic Lymphocytic Leukemia Research (64 papers), Acute Lymphoblastic Leukemia research (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (20 papers) and Hematopoietic Stem Cell Transplantation (16 papers). The work is most often cited by research in Hematology (3.9k citations), Genetics (1.6k citations), Cancer Research (1.1k citations), Molecular Biology (3.2k citations) and Oncology (942 citations). Alexander E. Perl has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Mark J. Levis, Martin Carroll, Ross L. Levine, Craig B. Thompson, Omar Abdel‐Wahab, Catherine C. Smith, Shinsan M. Su, Jay Patel, Valeria R. Fantin and Hilary A. Coller. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Transplantation and Cellular Therapy and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact